Nov 10, 2020 / 01:30PM GMT
Operator
Good day, everyone, and thank you for standing by, and welcome to Affimed's Third Quarter 2020 Financial Results and Corporate Update Conference Call. As a reminder, today's conference call is being recorded.
I would now like to introduce to -- your host for today's conference call, sir Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Alexander Fudukidis - Affimed N.V. - Head of IR
Thank you, operator. I'd like to welcome and thank you all for joining us today for Affimed's Third Quarter 2020 Financial Results and Operating -- Operational Update Call.
Before we begin, I'd like to remind everyone that the press release issued earlier today related to our earnings call can be found on the Investor Relations section of our website. We have also posted update slides -- updated slides that will be used to guide our discussion today.
On the call today, we have Dr. Adi Hoess, our Chief Executive Officer; Andreas Harstrick, our Chief Medical Officer; Arndt Schottelius, our Chief Scientific Officer; Dr. Wolfgang Fischer
Q3 2020 Affimed NV Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
